The Doctors Company Announces $7.3 Million Member Dividend
The Doctors Company announced today that it has approved a 2022 premium dividend of approximately $7.3 million, bringing the total of declared dividends to date to more than $446 million.
Search
Psychiatry Resources
Get risk management/patient safety resources and free accredited education opportunities for clinicians providing psychiatry care.
Professional Education
Module 5: Eliminating Stigma Through Clinical Understanding of Substance Use Disorder (Innovations for Smart Approaches in Safe Prescribing)
You will explore how having a working awareness of neurobiology, psychology, and heritability of addiction positively impacts holistic treatment of opioid misuse. This module will examine how the etiology of stigma and how internalized biases impact the care of patients who misuse opioids. Lastly, this program will provide resources on how to connect to treatment for substance use disorder. This module consists of five audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
Jun 05, 2025
Foundation Receives Record Number of Grant Entries for 2025
In the 2025 grant cycle, The Doctors Company Foundation received a record number of Letters of Intent—107 letters were submitted by the March 19 deadline. The Foundation’s grant review committee will now have the challenging task of evaluating those submissions to select a limited number of projects to move forward to the second phase of the grant making process.
From
The Doctor’s Advocate
December 03, 2025, Physicians Practice
Top 7 Considerations for Telehealth in 2026
The clinical and regulatory landscape for telehealth continues to evolve rapidly. Medical and dental practices face a wide range of changing regulations, complicated payment issues, and growing patient safety risks. Julie Ritzman, MBA, CPHRM, Senior Vice President of Patient Safety and Risk Management at The Doctors Company, provides seven telehealth considerations for clinicians heading into 2026.
AM Best Affirms The Doctors Company’s ‘A’ Excellent Financial Rating
August 23, 2022: AM Best has affirmed The Doctors Company's financial strength rating (FSR) of A (Excellent) and its long-term issuer credit rating (ICR) of "a+”. The outlook of these ratings is stable.
Professional Education
Delayed, Wrong, or Missed: Diagnostic Process Failure in Nurse Practitioner Practice
Diagnostic process failure resulting in delayed, wrong, or missed diagnoses has been identified as a serious and often preventable harm in healthcare. To prevent diagnostic error, nurse practitioners (NPs) should be aware of the most misdiagnosed conditions and understand the risks associated with cognitive bias. This course will help NPs understand the 12-step diagnostic process of care framework and determine where contributing factors exist in their primary practice setting to effectively recognize and implement appropriate improvement strategies.
Dec 02, 2024
Foundation Announces 2024 Grant Recipients
The Doctors Company Foundation awarded three new grants in 2024.
From
The Doctor’s Advocate
Set Expectations for New Patients With a Conditions of Treatment Agreement
Consider developing a plan to preemptively manage challenging patient behaviors when they are first identified.
December 15, 2023, Inside Medical Liability
MPL Cases: What Are the Primary Drivers of High-Indemnity Medical Malpractice Claims?
Jacqueline Ross, RN, PhD, Coding Director, and Kathrine Soulsby, RN, BSN, Senior Patient Safety Analyst, The Doctors Company, part of TDC Group, investigate high-dollar medical malpractice litigation and explain how reducing diagnostic errors is paramount to enhancing patient safety and mitigating loss costs.
